Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neoplasm Metastasis × orteronel × Clear all

Phase

Status

Withdrawn 2 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 10 Neoplasm Metastasis 1 Breast Neoplasms 1

Interventions

Gemcitabine 57 Capecitabine 51 Paclitaxel 49 Fluorouracil 47 Oxaliplatin 45 Bevacizumab 45 Leucovorin 39 Docetaxel 39 Nivolumab 37 Carboplatin 32 Cisplatin 31 Irinotecan 30 pembrolizumab 28 Cetuximab 28 Radiosurgery 26 Trastuzumab 25 Radiotherapy 22 Everolimus 20 Sorafenib 18 Pemetrexed 17 Cyclophosphamide 17 Prednisone 16 Panitumumab 16 Ipilimumab 16 Doxorubicin 15 Zoledronic Acid 14 Erlotinib Hydrochloride 14 Albumin-Bound Paclitaxel 14 Lapatinib 13 Fulvestrant 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00569153 2016-04-04

TAK-700

Millennium Pharmaceuticals, Inc.

Phase 1/2 Completed

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡